Italian startup Diadem raises €10M to develop a platform for early Alzheimer’s detection

Funding Rounds

▤ Summary

Brescia, Italy-based Diadem SpA, a company developing the first blood-based test for the early prediction of Alzheimer‘s disease (AD), announced on Monday that it has raised €10M in the first tranche of its equity funding. This new funding comes after the company’s earlier grant of €7.5M from the European Investment Bank (EIB).

$ Funding

$
Amount - Total raised
□
Date - Announcement date
◎
Investors CDP Venture Capital SGR - Fondo Nazionale Innovazione Lead investors
▥
Company - Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies